Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Sclerosis and CYP2D6[original query] |
---|
Multiple sclerosis and exposure to organic solvents, investigated by genetic polymorphisms of the GSTM1 and CYP2D6 enzyme systems. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2003 Nov 24 (4): 248-51. Landtblom A M, Wastenson M, Ahmadi A, Söderkvist |
Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis. European journal of clinical pharmacology 2009 Oct 65 (10): 971-6. Skretkowicz Jadwiga, Baranska Malgorzata, Rychlik-Sych Mario |
Significance of genetic polymorphism of CYP2D6 in the pathogenesis of systemic sclerosis. Pharmacological reports : PR 2012 64 (2): 336-42. Bara?ska Ma?gorzata, Dziankowska-Bartkowiak Bo?ena, Waszczykowska El?bieta, Rychlik-Sych Mariola, Skr?tkowicz Jadwi |
Genetic polymorphism of CYP2D6 in patients with systemic lupus erythematosus and systemic sclerosis. Autoimmunity 2016 Jan 1-6. Bara?ska Ma?gorzata, Rychlik-Sych Mariola, Kaszuba Andrzej, Dziankowska-Bartkowiak Bo?ena, Skr?tkowicz Jadwiga, Waszczykowska El?bie |
A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information. PloS one 2017 12 (1): e0169214. Silva-Alves Mariana S, Secolin Rodrigo, Carvalho Benilton S, Yasuda Clarissa L, Bilevicius Elizabeth, Alvim Marina K M, Santos Renato O, Maurer-Morelli Claudia V, Cendes Fernando, Lopes-Cendes Isc |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: